TheraRadar
Clinical-Stage Companies / Changchun BCHT Biotechnology

Changchun BCHT Biotechnology

Pre-Approval PRO BETA
12
Total Trials
5
Phase 3
1
Phase 2
1
Recruiting
135
Score

Pipeline by Phase

Phase 3
5
Phase 2
1
Phase 1
4

Therapeutic Focus

Influenza Rabies Prevention Pertussis (Whooping Cough) Diphtheria Tetanus

Clinical Trials (12)

NCT07112144 Phase 3 RECRUITING

Adsorption of Cell-free Diphtheria and Tetanus (Three-component) Combined With Vaccine Phase III Clinical Trial

Started: 6/13/2025

NCT07500207 Phase 3 ENROLLING BY INVITATION

A Phase III Clinical Trial on Immunogenicity and Safety of Lyophilized Rabies Vaccine for Human Use (Human Diploid Cell)

Started: 3/4/2026

NCT07133802 Phase 3 NOT YET RECRUITING

Clinical Trial to Evaluate the Protective Efficacy and Safety of a Nasal Spray Live Attenuated Influenza Vaccine (LAIV) in Adults Aged 18-59 Years Post-Vaccination

Started: 8/1/2025

NCT04334577 Phase 3 COMPLETED

Study on Efficacy of Attenuated Zoster Vaccine, Live

Started: 4/20/2020

NCT02964065 Phase 3 COMPLETED

A Trial on the Efficacy, Safety and Immunogenicity of Live-Attenuated Influenza Vaccine (LAIV)

Started: 11/1/2016

NCT06548139 Phase 2 NOT YET RECRUITING

Rabies mAb CBB 1 Combination Vaccine in Healthy People With Antibody Neutralization Activity and Safety Phase Clinical Trials

Started: 7/31/2024

NCT07492303 Phase 1 NOT YET RECRUITING

A Phase I Clinical Trial of Absorbed Acellular Pertussis (Two-Component) Diphtheria-Tetanus Combined Vaccine (For Adults and Adolescents)

Started: 4/20/2026

NCT07349017 Phase 1 NOT YET RECRUITING

A Phase I Trial to Evaluate the Safety and Immunogenicity of Influenza Virus Split Vaccine (Adjuvant)

Started: 2/7/2026

NCT07338786 Phase 1 ENROLLING BY INVITATION

A Phase I Clinical Trial to Evaluate the Safety of Different Immunization Schedules of a Lyophilized Human Rabies Vaccine (Human Diploid Cell)

Started: 9/13/2025

NCT07330440 Phase 1 ENROLLING BY INVITATION

A Phase I Study to Evaluate the Safety, Tolerability, and Immunogenicity of an mRNA Vaccine Against Herpes Simplex Virus Type 2 (HSV-2) Post-Vaccination

Started: 10/13/2025

NCT06961721 Phase 4 NOT YET RECRUITING

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase IV Clinical Trial to Evaluate the Immunogenicity and Safety of a Live Attenuated Herpes Zoster Vaccine in Adults Aged 40 Years and Older

Started: 5/1/2025

NCT07545564 Phase 4 ENROLLING BY INVITATION

A Study on Mucosal Specific IgA Immunokinetics After Administration of Nasal Spray Live Attenuated Influenza Vaccine

Started: 4/9/2026

Drug Candidates

Experimental Lyophilized Human Rabies Vaccine (Human Diploid Cell) approved Rabies vaccine Tdap vaccine influenza vaccine(BK01 adjuvnat) approved influenza vaccine adjuvant placebo placebo Lyophilized Human Rabies Vaccine (Human Diploid Cell) Low-Dose Cohort Mid-Dose Cohort
Activity Status: Active
Last Trial Started: 4/20/2026
Last Trial Ended: 7/18/2021
Trials (12 months): 8
Completed Trials: 2
Data sourced from ClinicalTrials.gov. This company has no FDA-approved drugs.